Fourth Annual Clinical & Postdoctoral Fellowship Competition from NMD4C, MDC to Open Fall 2024
NMD4C together with Muscular Dystrophy Canada (MDC) are excited to announce that our annual Neuromuscular Fellowship Competition will open again this fall for a fourth year! Please mark the following dates in your calendar:
2025 Neuromuscular Fellowship Competition Deadlines:
- Competition Opens: September 3, 2024
- Competition Closes: October 15, 2024
This annual funding competition provides salary support for early-career scientists to conduct postdoctoral studies in a laboratory focused on research of NMDs, and early-career clinicians to participate in neuromuscular medicine and electromyography fellowship training programs. For more information on the scope and guidelines of this competition, please consult either the postdoctoral fellowship competition guidelines here or clinical fellowship competition guidelines here. We will provide more information closer to the competition launch!
Read next...
Hope on the Horizon: Trials, Treatments and Therapies for DMD, DM1 & MG
Nov 25-28, 2025 | Join us at Hope on the Horizon to learn more about the treatment and clinical trial landscape for Duchenne Muscular Dystrophy, Myotonic Dystrophy Type 1 and Myasthenia Gravis from key experts in the field!
2026 Awards Now Open for Nominations!
We’re proud to recognize outstanding achievements across the neuromuscular research community with our Three awards: Publication of the Year, Early Career Biomedical/Clinical Researchers of the Year.
A Milestone in Neuromuscular Care: AGAMREE® (vamorolone) Approved as the First Treatment for Duchenne Muscular Dystrophy in Canada
Health Canada has approved AGAMREE® (vamorolone), the first-ever treatment for Duchenne Muscular Dystrophy (DMD) in Canada. Patient Support Program opens for enrollment on October 10, 2025.